Shenzhen Haorui Pharmatech Co., Ltd.

US FDA audit approved and EDQM approved, focus on oncology APIs, anti-depression APIs Dasatinib, Irinotecan HCl, Docetaxel anhydrous, Amisulpride, Desvenlafaxine Succinate, Flumazenil, Granisetron HCl, Neosigmine